ACZ ACN 01. A phase 4, double-blind, multicenter, randomized, vehicle-controlled, cross-over study to further evaluate the risk of hematological adverse events in G6PD [glucose-6-phosphate dehydrogenase]-deficient subjects with acne vulgaris treated with ACZONE dapsone) gel, 5%
Phase of Trial: Phase IV
Latest Information Update: 27 May 2011
At a glance
- Drugs Dapsone (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions; Registrational
- 23 Nov 2005 New trial record.